Status:
UNKNOWN
Protein Supplementation: Body Composition, Muscle Strength and Postural Balance
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Diabetes Mellitus, Type 2
Protein Supplementation
Eligibility:
MALE
65-79 years
Phase:
NA
Brief Summary
Nutritional interventions witch stimulate the rate of muscle protein synthesis are relevant for the development of therapeutic strategies aimed at attenuating the loss of mass and muscle strength rela...
Detailed Description
Eligibility Criteria: Diabetes mellitus type 2 with stable dose of medication (oral antidiabetic or insulin or combination of both) for three months or more. Glycated hemoglobin between 6 and 8.5% R...
Eligibility Criteria
Inclusion
- Diabetes mellitus type 2 with stable dose of medication (oral antidiabetic or insulin or combination of both) for three months or more.
- Glycated hemoglobin between 6 and 8.5%
- Renal function assessed by MDRD above 60 ml / h
- AST and ALT up to 2.5 times the upper limit of the
- No involvement of the musculoskeletal system with pain and any type of incapacitating disease or previous surgeries.
- No chronic non-communicable disease not treated properly and decompensated
- Renal function assessed by MDRD equal to or above 60 ml / h
Exclusion
- • Impossibility to conduct evaluation and training efficiently
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03792646
Start Date
May 1 2018
End Date
March 1 2020
Last Update
January 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Julia Maria DÀndrea Greve
São Paulo, Brazil, 04503-010